Abstract

Gut microbiota regulates the immune system, the development and progression of autoimmune diseases (AIDs) and overall health. Recent studies have played a crucial part in understanding the specific role of different gut bacterial strains and their metabolites in different AIDs. Microbial signatures in AIDs are revealed by advanced sequencing and metabolomics studies. Microbes such as sp. sp. sp., , sp. sp. sp. sp. sp. sp., sp. and sp. help maintain immune homeostasis; whereas, sp. sp. sp. sp., , , sp., and sp. cause immuno-pathogenesis. A complex web of interactions is revealed by understanding the influence of gut microbiota on immune cells and various T cell subsets such as CD4+ T cells, CD8+ T cells, natural killer T cells, γδ T cells, etc. Certain AIDs, including rheumatoid arthritis, diabetes mellitus, atopic asthma, inflammatory bowel disease and non-alcoholic fatty liver disease exhibit a state of dysbiosis, characterized by alterations in microbial diversity and relative abundance of specific taxa. This review summarizes recent developments in understanding the role of certain microbiota composition in specific AIDs, and the factors affecting specific regulatory T cells through certain microbial metabolites and also focuses the potential application and therapeutic significance of gut microbiota-based interventions as novel adjunctive therapies for AIDs. Further research to determine the precise association of each gut bacterial strain in specific diseases is required.

MeSH

Diabetes Mellitus, Cells, Natural Killer T-Cells, Autoimmune Diseases, Therapeutics, Gastrointestinal Microbiome, Microbiota

Cited by

• Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study. J Immunother Cancer, 2025
• The Role of the Gut Microbiota in Female Reproductive and Gynecological Health: Insights into Endometrial Signaling Pathways. Life (Basel), 2025
• Interacting roles of gut microbiota and T cells in the development of autoimmune hepatitis. Front Immunol, 2025
• The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. Sci Rep, 2025
• Stir-baked Xanthii fructus ameliorates adjuvant arthritis by regulating gut microbiota, short-chain fatty acids and metabolites. Front Microbiol, 2025
• Overview of Microorganisms: Bacterial Microbiome, Mycobiome, Virome Identified Using Next-Generation Sequencing, and Their Application to Ophthalmic Diseases. Microorganisms, 2025
• Recent insights and advances in gut microbiota's influence on host antiviral immunity. Front Microbiol, 2025
• Characterization of Gut Microbiota in Patients with Active Spreading Vitiligo Based on Whole-Genome Shotgun Sequencing. Int J Mol Sci, 2025
• Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies. World J Gastrointest Pharmacol Ther, 2025
• The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches. Front Immunol, 2025